Phase 3 Trial to Evaluate IVIG, Aspirin, Prednisolone Combination Therapy in Patients With Kawasaki Disease Pharmacy Times, 16 Dec 2021 Trial seeks to provide high-level evidence for improving the initial treatment for acute Kawasaki disease.